Skip to content

APOTHEEK VANDERVOORT: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK VANDERVOORT

BE 0440.513.127
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€10,004
2024 · €8,448+€1,556
Equity
€605,237
2024 · €595,232+€10,004
Cash
€142,558
2024 · €132,592+€9,966
Balance sheet total
€644,949
2024 · €636,334+€8,615

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€10,248

    down €10,248 (-14.1%), from €72,777 to €62,528

    of which Furniture and vehicles: -€6,119

  • Cash +€9,966

    up €9,966 (+7.5%), from €132,592 to €142,558

    mainly Depreciation (+€12,448) and Net result for the year (+€10,004)

Equity and liabilities
  • Reserves +€10,004

    up €10,004 (+3.0%), from €336,202 to €346,206

    of which Distributable reserves: +€10,004

Income statement
  • Gross operating margin +€1,665

    up €1,665 (+6.8%), from €24,403 to €26,068

  • Depreciation -€1,177

    down €1,177 (-8.6%), from €13,625 to €12,448

  • Taxes +€1,017

    up €1,017 (+30.4%), from €3,349 to €4,365

  • Financial income -€725

    down €725 (-6.9%), from €10,544 to €9,819

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €8,448
Gross operating margin +€1,665
Depreciation +€1,177
Other operating charges +€209
Financial income -€725
Financial charges +€247
Taxes -€1,017
Result 2025 €10,004
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€12,166
Investment -€2,200
Financing €0
Cash 2024 €132,592
Net result for the year +€10,004
Depreciation +€12,448
Stocks and contracts -€3,196
Receivables within one year -€5,618
Deferred charges and accrued income -€84
Trade debts -€1,029
Tax, wage and social debts -€120
Other debts -€239
Investment in fixed assets (net) -€2,200
Cash 2025 €142,558
brings cash intakes cash out
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €636,334 €644,949 +€8,615 +1.4%
Fixed assets 21/28 €72,777 €62,528 -€10,248 -14.1%
Tangible fixed assets 22/27 €72,777 €62,528 -€10,248 -14.1%
Land and buildings 22 €63,100 €58,972 -€4,129 -6.5%
Furniture and vehicles 24 €9,676 €3,557 -€6,119 -63.2%
Current assets 29/58 €563,557 €582,421 +€18,863 +3.3%
Stocks and contracts in progress 3 €68,519 €71,715 +€3,196 +4.7%
Stocks 30/36 €68,519 €71,715 +€3,196 +4.7%
Amounts receivable within one year 40/41 €111,184 €116,802 +€5,618 +5.1%
Trade receivables 40 €107,822 €112,058 +€4,236 +3.9%
Other amounts receivable 41 €3,362 €4,744 +€1,382 +41.1%
Current investments 50/53 €250,000 €250,000 = 0.0%
Cash at bank and in hand 54/58 €132,592 €142,558 +€9,966 +7.5%
Deferred charges and accrued income 490/1 €1,263 €1,346 +€84 +6.6%
Total equity and liabilities 10/49 €636,334 €644,949 +€8,615 +1.4%
Equity 10/15 €595,232 €605,237 +€10,004 +1.7%
Contributions 10/11 €259,030 €259,030 = 0.0%
Capital 10 €258,603 €258,603 = 0.0%
Issued capital 100 €258,603 €258,603 = 0.0%
Contributions outside capital 11 €427 €427 = 0.0%
Share premium 1100/10 €427 €427 = 0.0%
Reserves 13 €336,202 €346,206 +€10,004 +3.0%
Non-distributable reserves 130/1 €25,860 €25,860 = 0.0%
Legal reserve 130 €25,860 €25,860 = 0.0%
Tax-exempt reserves 132 €28,663 €28,663 = 0.0%
Distributable reserves 133 €281,679 €291,683 +€10,004 +3.6%
Profit (loss) carried forward 14 €0 - =
Provisions and deferred taxes 16 €0 - =
Provisions for liabilities and charges 160/5 €0 - =
Other liabilities and charges 164/5 €0 - =
Amounts payable 17/49 €41,101 €39,713 -€1,389 -3.4%
Amounts payable within one year 42/48 €41,101 €39,713 -€1,389 -3.4%
Trade debts 44 €31,126 €30,097 -€1,029 -3.3%
Suppliers 440/4 €31,126 €30,097 -€1,029 -3.3%
Taxes, remuneration and social security 45 €1,070 €950 -€120 -11.2%
Taxes 450/3 €1,070 €950 -€120 -11.2%
Other amounts payable 47/48 €8,905 €8,666 -€239 -2.7%
Accrued charges and deferred income 492/3 €0 - =
Non-recurring operating income 76A €559 €0 -€559 -100%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €13,625 €12,448 -€1,177 -8.6%
Other operating charges 640/8 €6,036 €5,828 -€209 -3.5%
Gross operating margin 9900 €24,403 €26,068 +€1,665 +6.8%
Operating profit (loss) 9901 €4,741 €7,792 +€3,051 +64.3%
Financial income 75/76B €10,544 €9,819 -€725 -6.9%
Recurring financial income 75 €10,544 €9,819 -€725 -6.9%
Financial charges 65/66B €3,489 €3,242 -€247 -7.1%
Recurring financial charges 65 €3,489 €3,242 -€247 -7.1%
Profit (loss) for the period before taxes 9903 €11,797 €14,369 +€2,573 +21.8%
Income taxes 67/77 €3,349 €4,365 +€1,017 +30.4%
Profit (loss) for the period 9904 €8,448 €10,004 +€1,556 +18.4%
Profit (loss) for the period to be appropriated 9905 €8,448 €10,004 +€1,556 +18.4%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.